Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Effects of Bacille Calmette-Guérin after the first demyelinating event in the CNS.
[A Case of Neuromyelitis Optica with Relapse Symptoms from Paroxysmal Pruritus].
Cognitive-motor related brain activity during walking: differences between men and women with multiple sclerosis.
The mechanisms of neurotoxicity and the selective vulnerability of nervous system sites.
TLR4-activated microglia require IFN-γ to induce severe neuronal dysfunction and death in situ.
Brain atrophy: an in-vivo measure of disease activity in multiple sclerosis.
Disclosure of diagnosis of multiple sclerosis in the workplace positively affects employment status and job tenure.
Effect of Mindfulness-Based Stress Reduction on Anxiety, Depression and Stress in Women With Multiple Sclerosis.
Inhibition of Epidermal Growth Factor Receptor Improves Myelination and Attenuates Tissue Damage of Spinal Cord Injury.
Can we define a rehabilitation strategy for cognitive impairment in progressive multiple sclerosis? A critical appraisal.
Supernumerary phantom limbs in ICU patients with acute inflammatory demyelinating polyneuropathy.
Continuous evolution of magnetic resonance imaging in multiple sclerosis.
Multiple Sclerosis and Antibodies against KIR4.1.
Innate Immunotherapeutics announces clinical trial fully enrolled and receives strong interest from potential Pharma partners
Hereditary diffuse leukoencephalopathy with spheroids with phenotype of primary progressive multiple sclerosis.
Immune cell dynamics in the CNS: Learning from the zebrafish.
Integrin alpha L controls the homing of regulatory T cells during CNS autoimmunity in the absence of integrin alpha 4.
Vitamin D Binding Protein Isoforms and Apolipoprotein E in Cerebrospinal Fluid as Prognostic Biomarkers of Multiple Sclerosis.
Multiple sclerosis: Grey matter atrophy in the thoracic spinal cord is associated with disability in patients with multiple sclerosis.
Immunodetection of outer membrane proteins by flow cytometry of isolated mitochondria.
Sarcoidosis with neurological involvement imitating multiple sclerosis: The importance of thoracic imaging.
Normatization of the symbol digit modalities test-oral version in a latin american country.
Fatigue in patients with multiple sclerosis: is it related to pro- and anti-inflammatory cytokines?
The Severity of Bowel Dysfunction in Patients with Neurogenic Bladder.
Patient expression of emotions and neurologist responses in first multiple sclerosis consultations.
Pages
« first
‹ previous
…
524
525
526
527
528
529
530
531
532
…
next ›
last »